These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 19111635)

  • 21. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
    Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4.
    Stavroulopoulos A; Porter CJ; Roe SD; Hosking DJ; Cassidy MJ
    Nephrology (Carlton); 2008 Feb; 13(1):63-7. PubMed ID: 18199106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density.
    Allali F; El Aichaoui S; Khazani H; Benyahia B; Saoud B; El Kabbaj S; Bahiri R; Abouqal R; Hajjaj-Hassouni N
    Semin Arthritis Rheum; 2009 Jun; 38(6):444-51. PubMed ID: 18336870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study.
    Mendes MM; Hart KH; Lanham-New SA; Botelho PB
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31167443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
    Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
    Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels].
    Rodríguez Villarreal I; Ortega O; Gallar P; Sánchez M; Callejas R; Gracia C; García la Calle C; Ortiz M; Herrero JC; Mon C; Oliet A; Vigil A
    Nefrologia; 2011; 31(2):185-91. PubMed ID: 21461012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women.
    Malavolta N; Pratelli L; Frigato M; Mulè R; Mascia ML; Gnudi S
    Osteoporos Int; 2005 Dec; 16(12):1691-7. PubMed ID: 15959621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
    Gannagé-Yared MH; Farès C; Ibrahim T; Rahal ZA; Elias M; Chelala D
    Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.
    Al-Aly Z; Qazi RA; González EA; Zeringue A; Martin KJ
    Am J Kidney Dis; 2007 Jul; 50(1):59-68. PubMed ID: 17591525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.
    Okoye JU; Arodiwe EB; Ulasi II; Ijoma CK; Onodugo OD
    Afr Health Sci; 2015 Sep; 15(3):941-8. PubMed ID: 26957985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure.
    Fahrleitner-Pammer A; Dobnig H; Dimai HP; Holzer H; Benesch T; Borchhardt K; Cejka D; Haas M
    Clin Nephrol; 2009 Jun; 71(6):652-9. PubMed ID: 19473634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective.
    Kuchuk NO; van Schoor NM; Pluijm SM; Chines A; Lips P
    J Bone Miner Res; 2009 Apr; 24(4):693-701. PubMed ID: 19049341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease.
    Elder GJ; Mackun K
    J Bone Miner Res; 2006 Nov; 21(11):1778-84. PubMed ID: 17002574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of FGF-23 measurement in dialysis patients.
    Jongbloed F; Galassi A; Cozzolino M; Zietse R; Chiarelli G; Cusi D; Brancaccio D; Gallieni M
    Clin Nephrol; 2011 Sep; 76(3):201-9. PubMed ID: 21888857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians.
    Arya V; Bhambri R; Godbole MM; Mithal A
    Osteoporos Int; 2004 Jan; 15(1):56-61. PubMed ID: 13680103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High serum 25-hydroxyvitamin D levels do not retard postmenopausal bone loss in Japanese women: the Yokogoshi study.
    Kitamura K; Nakamura K; Saito T; Kobayashi R; Oshiki R; Nishiwaki T; Iwasaki M; Yoshihara A
    Arch Osteoporos; 2013; 8():153. PubMed ID: 24105337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.